Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
138.8 USD | +2.54% | -1.68% | +4.83% |
May. 31 | Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing | MT |
May. 28 | Neurocrine Biosciences Says CEO Kevin Gorman Retiring | MT |